Clearstead Advisors’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-860
Closed -$24K 1034
2020
Q3
$24K Buy
+860
New +$24K ﹤0.01% 565